Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Merit Medical Systems (MMSI) Accumulated Depreciation & Amortization (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $376.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 7.06% to $376.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $376.4 million through Dec 2025, up 7.06% year-over-year, with the annual reading at $376.4 million for FY2025, 7.06% up from the prior year.
  • Accumulated Depreciation & Amortization hit $376.4 million in Q4 2025 for Merit Medical Systems, roughly flat from $377.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $377.8 million in Q3 2025 to a low of $265.9 million in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $322.3 million across 5 years, with a median of $323.4 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 11.11% in 2021 and later increased 6.15% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $280.6 million in 2021, then rose by 8.07% to $303.3 million in 2022, then increased by 8.5% to $329.0 million in 2023, then grew by 6.86% to $351.6 million in 2024, then rose by 7.06% to $376.4 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for MMSI at $376.4 million in Q4 2025, $377.8 million in Q3 2025, and $371.7 million in Q2 2025.